3 authorised products containing Amivantamab, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Rybrevant 1 600 mg solution for injection EU/1/21/1594/002 |
Amivantamab | Janssen-Cilag International NV | — |
| Rybrevant 2240 mg solution for injection EU/1/21/1594/003 |
Amivantamab | Janssen-Cilag International NV | — |
| Rybrevant 350 mg concentrate for solution for infusion EU/1/21/1594/001 |
Amivantamab | Janssen-Cilag International NV | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.